The studies show that the inhibition of SIK3 in vitro and in vivo can suppress the function of the transcription factor MEF2C and inhibit the proliferation of AML cells, either with small molecule inhibitors or genetically [91]. This evidence concerns the gene MEF2C and acute myeloid leukemia.